세계의 의료용 가스 및 장비 시장 예측 : 제품별, 용도별, 최종 사용자별, 지역별 분석(-2030년)

According to Stratistics MRC, the Global Medical Gases and Equipment Market is accounted for $27.06 billion in 2024 and is expected to reach $48.46 billion by 2030 growing at a CAGR of 10.2% during the forecast period. Medical gases and equipment are crucial for various healthcare applications, including anesthesia, respiratory therapy, and patient life support. Common medical gases include oxygen, nitrous oxide, medical air, and carbon dioxide, each serving specific therapeutic purposes. Medical gas equipment encompasses devices such as flow meters, regulators, cylinders, and medical gas pipelines, ensuring the safe and precise delivery of these gases to patients. Proper management and maintenance of this equipment are vital to ensuring patient safety and the effectiveness of treatments.

According to WHO data, more than 3.0 million people die each year from Chronic Obstructive Pulmonary Disease (COPD), which accounts for approximately 6% of all deaths worldwide and can potentially become the world's third leading cause of death by 2030.

Market Dynamics:

Driver:

Growing Demand for Home Healthcare

The demand of home healthcare is increasing due to growing geriatric population, as it is the integral part of the primary healthcare service. Home healthcare provides older patients a better quality of life in their homes, limits the length of hospitalization, and provide more efficient treatment and continuous monitoring for greater efficacy. The advancement in home automation, remote medical assistance and pharmacology facilitates the development of technologies, such as respiratory assistance solutions; infusion system and external insulin pump systems, which assists the home delivery treatment for chronic disease patients. Therefore, it would lead to increase in demand of market in the home care setting.

Restraint:

Helium Scarcity

Helium is extensively used for several applications in the healthcare industry, such as in medical imaging and as a carrier gas in GC and GC-MS procedures. Worldwide, the US accounts for a majority share of helium production. The helium taken out of the stockpiled federal helium reserve accounted for over one-third of the global helium supplies. The US government planned to shut down the oldest helium reservoir in Texas. This legislation emphasized that helium from the reserve should be drawn down at a slower rate and at higher prices to facilitate a smoother transition and prevent the rapid decline in the price of helium in the global market. This can negatively affect the growth of the overall market.

Opportunity:

Technological Advancements

The nature of the market for home care, in particular, is continuously changing owing to the availability of smaller and less-expensive equipment in the market. Considering the growth opportunities in this market space, several players are focusing on launching advanced products. Technological developments have provided a mounting range of functionality alternatives for several medical gas handling equipments used in hospital care and home care. Additionally, numerous associated medical gas equipments are gradually being improved to offer a better quality of care. The development of lightweight and portable medical gas handling equipment has emerged as a boon to the growing home healthcare market.

Threat:

Regulatory Concern

The rules were introduced and they stressed the significance of regular servicing and periodic inspection of medical gas and vacuum equipment. Such regulatory changes raise the operational expenses of medical gas makers and distributors while also putting downward pressure on their pricing strategies. Medical gas and device producers and medical gas distributors are projected to suffer as a result of this, which will hurt their profit margins. Medical gases, and subsequently medical gas equipment, play a crucial role in the smooth functioning of the modern healthcare sector.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the medical gases and equipment market, driving unprecedented demand for oxygen and respiratory care devices. The surge in COVID-19 cases led to a critical need for oxygen therapy and ventilators, boosting market growth. Hospitals and healthcare facilities globally increased their stock of medical gases and equipment to treat severe respiratory symptoms caused by the virus. Additionally, increased investments in healthcare infrastructure and technological advancements were observed, further propelling market expansion.

The medical gas segment is expected to be the largest during the forecast period

The medical gas segment within the medical gases and equipment market is experiencing significant growth driven by several factors. The increasing prevalence of chronic diseases such as COPD, asthma, and other respiratory disorders has escalated the demand for medical gases like oxygen and nitrous oxide. Additionally, the expanding elderly population, which is more prone to such conditions, further fuels this demand. Technological advancements in gas delivery systems and increased healthcare infrastructure development in emerging economies are also contributing to market expansion.

The therapeutic segment is expected to have the highest CAGR during the forecast period

The therapeutic segment in the medical gases and equipment market is experiencing significant growth, driven by the increasing prevalence of chronic respiratory diseases. The rising geriatric population, which is more susceptible to respiratory conditions, further propels the demand for therapeutic medical gases like oxygen and associated equipment. Innovations in gas delivery systems and advancements in home healthcare solutions are enhancing patient accessibility and convenience. Additionally, the expansion of healthcare infrastructure and increasing awareness about respiratory health contribute to this segment's growth.

Region with largest share:

The North America is projected to hold the highest market share, due to the presence of well-established healthcare and pharmaceutical sectors. The growing incidences of COPD, asthma, and other medical conditions, such as cardiovascular and lifestyle-related diseases, are expected to drive the demand for medical gases and equipment in the United States, during the forecast period. The presence of state-of-the-art healthcare facilities, especially intensive care units, a well-established medical gas market, a high prevalence of patients with respiratory disorders, and the growing geriatric population have contributed to the largest share of the US market.

Region with highest CAGR:

Europe is projected to have the highest CAGR. The rising number of hospitals coupled with the increase in adoption of home healthcare settings in the countries such as the U.K, France, Italy, and others are propelling the growth of the Europe market. According to the (WHO), life expectancy has risen in the district in the last few decades. The European market is witnessing growth mainly due to the increasing prevalence of chronic diseases and lifestyle-associated diseases, increasing demand for home healthcare, and increasing prevalence of respiratory diseases. Among the European nations, Germany is the largest contributor to the medical gases and equipment industry and is projected to grow during the forecast period.

Key players in the market

Some of the key players in Medical Gases and Equipment market include Air Liquide, Air Products and Chemicals, Inc., Allied Healthcare Products Inc., Amico Corporation, Atlas Copco AB, GCE Holding, Gentec Corporation, Medical Gas Solutions Limited, Messer Group GmbH, Praxair, Inc., Rotarex S.A., SCI Analytical, SOL SPA, Taiyo Nippon Sanso Corporation (Matheson Tri-Gas Inc.) and The Linde Group.

Key Developments:

In March 2024, Taiyo Nippon Sanso Corp (TNSC) of Tokyo, Japan has developed a gas delivery system for high-purity hydrazine, compatible with the BRUTE Hydrazine of California-based subsidiary RASIRC Inc, which provides semiconductor processing materials and vapor-generation equipment. In the electronic device manufacturing industry, hydrazine gas is favoured for its superior reactivity over conventional nitriding sources, such as ammonia.

In November 2023, Industrial gas major Messer made headlines when it announced the completion of its takeover of Messer Industries, having acquired all shares in the company from CVC Capital Partners Fund VII (CVC). The impact of its takeover is set to be felt throughout the global industrial gases business - a sector that has been shaped by Messer, a company that is celebrating its 125th anniversary throughout the year under its '125uccess Story' slogan.

Products Covered:

• Medical Gas
• Medical Gas Equipment
• Biological Atmospheres

Applications Covered:

• Pharmaceutical Manufacturing and Research
• Diagnostics
• Therapeutic
• Other Applications

End Users Covered:

• Academic Institutes and Research Institutes
• Ambulatory Surgical Centers
• Biotechnology Industry
• Research Laboratories
• Emergency Services
• Home Healthcare
• Hospitals & Clinics

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Medical Gases and Equipment Market, By Product

• 5.1 Introduction
• 5.2 Medical Gas
  • 5.2.1 Pure Medical Gases
    • 5.2.1.1 Type
    • 5.2.1.1 Carbon Dioxide
    • 5.2.1.2 Helium
    • 5.2.1.3 Medical Air
    • 5.2.1.4 Nitrogen
    • 5.2.1.5 Nitrous Oxide
    • 5.2.1.6 Oxygen
    • 5.2.1.2 Form of Delivery
    • 5.2.1.2 Liquid Tanks
    • 5.2.1.3 High Pressure Cylinders
    • 5.2.1.4 Bulk Delivery
  • 5.2.2 Medical Gas Mixtures
    • 5.2.2.1 Blood-Gas Mixtures
    • 5.2.2.2 Breathing Zone Monitoring Calibration Standard
    • 5.2.2.3 Carbon Dioxide-Oxygen Mixtures
    • 5.2.2.4 Helium-Oxygen Mixtures
    • 5.2.2.5 Laser-Gas Mixtures
    • 5.2.2.6 Lung Diffusion Mixtures
    • 5.2.2.7 Medical Drug Gas Mixtures
    • 5.2.2.8 Nitrous Oxide-Oxygen Mixtures
    • 5.2.2.9 Oxyfume 2000
    • 5.2.2.10 Sterlant Gas Mixtures (Ethylene Oxide)
• 5.3 Medical Gas Equipment
  • 5.3.1 Equipment Accessories
    • 5.3.1.1 Valve with Integrated Pressure Regulator
    • 5.3.1.2 Vacuum Systems
    • 5.3.1.3 Suction Regulators
    • 5.3.1.4 Regulators
    • 5.3.1.5 Outlets
    • 5.3.1.6 Monitoring Systems (Alarms & Monitors)
    • 5.3.1.7 Medical Air Compressors
    • 5.3.1.8 Masks
    • 5.3.1.9 Manifolds
    • 5.3.1.10 Hose Assemblies and Valves
    • 5.3.1.11 Flowmeters
    • 5.3.1.12 Cylinders and Accessories
  • 5.3.2 Gas Delivery Systems
  • 5.3.3 Cryogenic Products (Freezers)
• 5.4 Biological Atmospheres
  • 5.4.1 Anaerobic Mixtures
  • 5.4.2 Aerobic Mixtures

6 Global Medical Gases and Equipment Market, By Application

• 6.1 Introduction
• 6.2 Pharmaceutical Manufacturing and Research
  • 6.2.1 Drug Discovery
  • 6.2.2 Pharmaceutical Manufacturing
  • 6.2.3 Process Development
  • 6.2.4 Quality Control
• 6.3 Diagnostics
  • 6.3.1 General Laboratory Use
  • 6.3.2 Medical Imaging
• 6.4 Therapeutic
  • 6.4.1 Respiratory Diseases
  • 6.4.2 Cryosurgery
  • 6.4.3 Cardiovascular Diseases
  • 6.4.4 Anesthesia
• 6.5 Other Applications
  • 6.5.1 Platelet Preservation
  • 6.5.2 Tissue

7 Global Medical Gases and Equipment Market, By End User

• 7.1 Introduction
• 7.2 Academic Institutes and Research Institutes
• 7.3 Ambulatory Surgical Centers
• 7.4 Biotechnology Industry
• 7.5 Research Laboratories
• 7.6 Emergency Services
• 7.7 Home Healthcare
• 7.8 Hospitals & Clinics

8 Global Medical Gases and Equipment Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Air Liquide
• 10.2 Air Products and Chemicals, Inc.
• 10.3 Allied Healthcare Products Inc.
• 10.4 Amico Corporation
• 10.5 Atlas Copco AB
• 10.6 GCE Holding
• 10.7 Gentec Corporation
• 10.8 Medical Gas Solutions Limited
• 10.9 Messer Group GmbH
• 10.10 Praxair, Inc.
• 10.11 Rotarex S.A.
• 10.12 SCI Analytical
• 10.13 SOL SPA
• 10.14 Taiyo Nippon Sanso Corporation (Matheson Tri-Gas Inc.)
• 10.15 The Linde Group